Biospecimen Collection to Identify Gene Mutations for High Risk Pancreatic Cancer in Pediatric Patients, INSPPIRE 2 Study

Inclusion Criteria

• •All subjects/parents must sign an informed consent and/or assent indicating that they are aware of the investigational nature of this study
• •Subjects/parents must have signed an authorization for the release of their or their child's protected health information
• •All children must be under 18 years of age at the time of enrollment
• •* Acute pancreatitis (AP): AP is defined as requiring 2 of the following:
• •* Abdominal pain compatible with AP
• •* Serum amylase and/or lipase values \>= 3 times upper limits of normal
• •* Imaging findings of AP, such as gland enlargement, acute inflammatory changes, and fluid collections
• •* ARP is defined as: At least 2 episodes of acute pancreatitis with complete resolution of pain and a \>= 1 month pain-free interval between episodes
• •* Chronic Pancreatitis:
• •* Children with at least:
• •* One irreversible structural change in the pancreas with or without abdominal pain +/- exocrine pancreatic insufficiency +/- diabetes
• •* Irreversible structural changes:
• •* Ductal calculi, dilated side branches, parenchymal calcifications found in any imaging (abdominal ultrasound \[abd US\], magnetic resonance imaging/magnetic resonance cholangiopancreatography \[MRI/MRCP\], computerized tomography \[CT\], endoscopic retrograde cholangiopancreatography \[ERCP\], endoscopic US \[EUS\])
• •* Ductal obstruction or stricture/dilatation/irregularities that are persistent (for \>= 2 months) on any imaging
• •* Parenchymal atrophy, irregular contour, accentuated lobular architecture, cavities alone are not diagnostic findings for CP
• •* Surgical or pancreatic biopsy specimen demonstrating histopathologic features compatible with CP (acinar atrophy, fibrosis, protein plugs, infiltration with lymphocytes, plasma cells, macrophages)